Conference item icon

Conference item

Quality of life in patients with advanced NSCLC treated in second- or third-line with nab-paclitaxel + durvalumab: abound.2l+

Publication status:
Published
Peer review status:
Reviewed (other)

Actions


Access Document


Files:
Publisher copy:
10.1016/j.jtho.2018.08.649

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Oncology
Role:
Author
ORCID:
0000-0002-0183-0642
Publisher:
Elsevier
Host title:
Journal of Thoracic Oncology
Journal:
Journal of Thoracic Oncology More from this journal
Volume:
13
Issue:
10
Pages:
S498-S499
Publication date:
2018-10-22
DOI:
EISSN:
1556-1380
ISSN:
1556-0864
Language:
English
Keywords:
Pubs id:
958269
Local pid:
pubs:958269
Deposit date:
2020-06-08

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP